EGFR and glioma: As a result of both experiments (EGFR and GFAP), we conclude that IgG binding to the EGFR phospho-peptide exists in plasma of glioma patients but not in plasma of healthy donors, and that autoantibodies against EGFR phospho-site S1166 are associated with high-grade glioma.